Kirkland Advises Carlyle on $3.8B Acquisition of Baxter's Kidney Care Segment
August 14, 2024
August 14, 2024
CHICAGO, Illinois, Aug. 14 -- Kirkland and Ellis, a law firm, issued the following news release:
Kirkland & Ellis is advising global investment firm Carlyle (NASDAQ: CG) on the $3.8 billion acquisition of global medtech company Baxter International Inc.'s (NYSE:BAX) kidney care segment, which will be named Vantive.
The transaction was announced on August 13, 2024. Under the terms of the definitive agreement, subject to certain closing adjustments, Baxter will r . . .
Kirkland & Ellis is advising global investment firm Carlyle (NASDAQ: CG) on the $3.8 billion acquisition of global medtech company Baxter International Inc.'s (NYSE:BAX) kidney care segment, which will be named Vantive.
The transaction was announced on August 13, 2024. Under the terms of the definitive agreement, subject to certain closing adjustments, Baxter will r . . .